Physician profile
Amanda Mcgahee
NPI 1831212737
$1,439.03
in general payments reported to CMS, 2019-2025
21 companies · $240 in 2025
The $240 reported for 2025 was more than what 79% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $80.13 · 2021: $235 · 2022: $333 · 2023: $178 · 2024: $97.90 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $515.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $245.40 | 2021-2025 | Azstarys |
| Cranial Technologies, INC | $175.57 | 2019-2025 | Doc Band |
| Glaxosmithkline, LLC. | $166.27 | 2019-2025 | Bexsero |
| Takeda Pharmaceuticals U.S.A., INC. | $159.80 | 2020-2021 | |
| Ironshore Pharmaceuticals INC. | $139.80 | 2019-2023 | Jornay Pm |
| Sanofi Pasteur INC. | $83.27 | 2023-2025 | |
| Abbott Laboratories | $74.25 | 2019 | |
| Merck Sharp & Dohme LLC | $63.17 | 2022-2025 | Gardasil 9, Vaxneuvance, Rotateq |
| Tris Pharma INC | $52.71 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $35.83 | 2023-2024 | Qelbree, Qelbree |
| Collegium Pharmaceutical, INC. | $31.01 | 2025 | Jornay Pm |
| Pfizer INC. | $29.61 | 2023 | |
| Alk-Abello, INC | $27.92 | 2025 | Neffy |
| Verrica Pharmaceuticals INC. | $26.53 | 2024 | Ycanth |
| Shire North American Group INC | $23.18 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $22.67 | 2024 | |
| Kaleo, INC. | $19.72 | 2022 | |
| Ars Pharmaceuticals Operations, INC. | $17.41 | 2025 | Neffy |
| Kowa Pharmaceuticals America, INC. | $17.31 | 2025 | Zoryve |
| Neos Therapeutics, LP | $14.37 | 2019 | |
| Adlon Therapeutics L.P. | $13.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Mcgahee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.